Amarin Corp Plcuk (AMRN) Cash from Financing Activities (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cash from Financing Activities of -$1.7 million for Q1 2026, down 50.76% YoY from -$3.4 million in Q1 2025, and down 42075.0% sequentially from -$4000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$1.7 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 50.76% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$2.6 million (down 129.05% YoY), while the FY2025 annual figure was -$2.0 million, down 40.96% from the prior year.
  • Cash from Financing Activities declined to -$1.7 million in Q1 2026, from -$4000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AMRN reached as high as $364000.0 in Q1 2023 and fell as low as -$1.7 million in Q1 2026.
  • The 5-year median for Cash from Financing Activities is -$68000.0 (2024), against an average of -$312529.4.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 172.08% — and 2025, when it tumbled 2050.0%.
  • A 5-year view of Cash from Financing Activities shows it stood at $38000.0 in 2022, then surged by 118.42% to $83000.0 in 2023, then sank by 79.52% to $17000.0 in 2024, then tumbled by 123.53% to -$4000.0 in 2025, then sank by 42075.0% to -$1.7 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$1.7 million, -$4000.0, and -$248000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -3.47 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 530.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 919.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 267.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -2.98 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.44 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -4.24 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -2.86 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -1.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.69 Mn
Mar 31, 2026 -1.69 Mn
Dec 31, 2025 -4,000.00
Dec 31, 2025 -4,000.00
Sep 30, 2025 -248,000.00
Sep 30, 2025 -248,000.00
Jun 30, 2025 -663,000.00
Jun 30, 2025 -663,000.00
Mar 31, 2025 -1.12 Mn
Mar 31, 2025 -1.12 Mn
Dec 31, 2024 17,000.00
Dec 31, 2024 17,000.00
Sep 30, 2024 -68,000.00
Sep 30, 2024 -68,000.00
Jun 30, 2024 34,000.00
Jun 30, 2024 34,000.00
Mar 31, 2024 -1.43 Mn
Mar 31, 2024 -1.43 Mn
Dec 31, 2023 83,000.00
Dec 31, 2023 83,000.00